Latest News about XBI
Recent news which mentions XBI
3 Biotech ETFs Overdue for a Bounce
March 19, 2024
From InvestorPlace
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
February 28, 2024
From Benzinga
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
February 28, 2024
From Benzinga
From InvestorPlace
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
From Benzinga
2023 in Review: Key Stock Trends and Sector Shifts Unveiled
January 05, 2024
From InvestorPlace
Satori Fund's Dan Niles Names Amazon, Meta Top Stocks To Own In 2024
January 03, 2024
From Benzinga
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024
January 03, 2024
From Motley Fool
3 Thematic Growth ETFs to Load Up on Right Now
December 30, 2023
From Motley Fool
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
December 14, 2023
From Benzinga
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
December 13, 2023
From Benzinga
Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
December 04, 2023
From Benzinga
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
December 01, 2023
From Benzinga
Top trades for 2024 encircle Big Tech, but not so much the stocks, Bank of America says
December 01, 2023
From MarketWatch
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
November 30, 2023
From Benzinga
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
November 29, 2023
From Benzinga
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
November 28, 2023
From Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
From InvestorPlace
From Motley Fool
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
October 06, 2023
From MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
From MarketWatch
Don’t Miss the Boom: 3 ETFs Set to Explode Higher
September 27, 2023
From InvestorPlace
VBI Vaccines’ pan-coronavirus vaccine candidate produced broad protection against variants of concern
September 27, 2023
From MarketWatch
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
From InvestorPlace
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
September 08, 2023
From Benzinga
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
August 25, 2023
From Benzinga
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
5 Meme Stocks to Sell Immediately, According to AI
August 22, 2023
From InvestorPlace
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
August 09, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.